CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma. - Cho MM; Song L; Quamine AE; Szewc F; Shi L; Ebben JD; Turicek DP; Kline JM; Burpee DM; Lafeber EO; Phillips MF; Ceas AS; et al. (Journal for immunotherapy of cancer, 2025)